In vitro and in vivo activities of benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis
Saito, H.; Tomioka, H.; Sato, K.; Hirata, T.; Hidaka, T.
Abstracts of the General Meeting of the American Society for Microbiology 94: 192
1994
ISSN/ISBN: 1060-2011 Accession: 031855477
Full Text Article emailed within 1 workday: $29.90
Related References
Hirata, T.; Saito, H.; Tomioka, H.; Sato, K.; Jidoi, J.; Hosoe, K.; Hidaka, T. 1995: In vitro and in vivo activities of the benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis Antimicrobial Agents and ChemoTherapy 39(10): 2295-2303Sato, K.; Tomioka, H.; Saito, H.; Kawahara, S.; Hidaka, T. 1996: In vitro activities of benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis Kekkaku: 71(8): 459-464
Yamamoto, Y.; Saito, H.; Tomioka, H.; Sato, K.; Yamane, T.; Yamashita, K.; Hosoe, K.; Hidaka, T. 1992: In vitro and in vivo activities of KRM-1648, a newly synthesized benzoxazinorifamycin, against Mycobacterium marinum Zentralblatt für Bakteriologie: International Journal of Medical Microbiology 277(2): 204-209
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 1996: Bacteriostatic and bactericidal activities of benzoxazinorifamycin Krm-1648 against Mycobacterium tuberculosis and Mycobacterium avium in human macrophages Antimicrobial Agents and Chemotherapy 40(6): 1482-1485
Mor, N.; Simon, B.; Heifets, L. 1996: Bacteriostatic and bactericidal activities of benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium in human macrophages Antimicrobial Agents and ChemoTherapy 40(6): 1482-1485
Saito, H.; Fujii, K.; Tomioka, H.; Sato, K.; Hidaka, T. 1992: In vitro activities of benzoxazinorifamycin krm 1648 against mycobacterium avium complex Abstracts of the General Meeting of the American Society for Microbiology 92: 181
Inderlied, C.B.; Barbara-Burnham, L.; Wu, M.; Young, L.S.; Bermudez, L.E. 1994: Activities of the benzoxazinorifamycin KRM 1648 and ethambutol against Mycobacterium avium complex in vitro and in macrophages Antimicrobial Agents and ChemoTherapy 38(8): 1838-1843
Saito, H.; Tomioka, H.; Sato, K. 1992: In vitro and in vivo antileprosy activities of benzoxazinorifamycin and clarithromycin International Journal of Leprosy and Other Mycobacterial Diseases 60(4): 723-724
Xu, J.; Wang, B.; Fu, L.; Zhu, H.; Guo, S.; Huang, H.; Yin, D.; Zhang, Y.; Lu, Y. 2019: In Vitro and in Vivo Activities of the Riminophenazine TBI-166 against Mycobacterium tuberculosis Antimicrobial Agents and ChemoTherapy 63(5)
Ji, B.; Lounis, N.; Truffot-Pernot, C.; Grosset, J. 1995: In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis Antimicrobial Agents and ChemoTherapy 39(6): 1341-1344
Shoen, C.; DeStefano, M.; Hafkin, B.; Cynamon, M. 2018: In Vitro and in Vivo Activities of Contezolid (MRX-I) against Mycobacterium tuberculosis Antimicrobial Agents and ChemoTherapy 62(8)
Alvirez-Freites, E.J.; Carter, J.L.; Cynamon, M.H. 2002: In vitro and in vivo activities of gatifloxacin against Mycobacterium tuberculosis Antimicrobial Agents and ChemoTherapy 46(4): 1022-1025
Upton, A.M.; Cho, S.; Yang, T.J.; Kim, Y.; Wang, Y.; Lu, Y.; Wang, B.; Xu, J.; Mdluli, K.; Ma, Z.; Franzblau, S.G. 2015: In vitro and in vivo activities of the nitroimidazole TBA-354 against Mycobacterium tuberculosis Antimicrobial Agents and ChemoTherapy 59(1): 136-144
Lu, Y.; Zheng, M.-Q.; Wang, B.; Zhao, W.-J.; Li, P.; Chu, N.-H.; Liang, B.-W. 2008: Activities of clofazimine against Mycobacterium tuberculosis in vitro and in vivo Zhonghua Jie he He Hu Xi Za Zhi 31(10): 752-755
Gay, J.D.; Deyoung, D.R.; Roberts, G.D. 1984: In vitro activities of norfloxacin and ciprofloxacin against mycobacterium tuberculosis mycobacterium avium complex mycobacterium chelonei mycobacterium fortuitum and mycobacterium kansasii Antimicrobial Agents and Chemotherapy 26(1): 94-96